Literature DB >> 11453562

Botulinum toxin in the treatment of cricopharyngeal dysphagia.

J J Haapaniemi1, E A Laurikainen, J Pulkkinen, R J Marttila.   

Abstract

Dysphagia is a common symptom in various neurological disorders affecting pharyngeal functions. Cricopharyngeal dysfunction is one of the major findings in these patients. The most effective treatment for restoring normal swallowing function in persistent cricopharyngeal dysfunction is cricopharyngeal myotomy, especially when mechanical obstruction or a well-localized neuromuscular dysfunction, such as a cricopharyngeal muscle spasm, is present. However, when there is a more diffuse neurological disorder present the results of surgery are more disappointing. In unclear cases, or in patients with temporary problems, no good method other than swallowing training, bougienage, and tube feeding are available. During the past decade, botulinum toxin has been found to be of therapeutic value in the treatment of a variety of neurological disorders associated with inappropriate muscular contractions such as torticollis and spasmodic dysphonia. Recently, injections of botulinum toxin in patients with cricopharyngeal muscle dysfunction have been reported to result in marked relief of dysphagia. In this article we describe our experiences with botulinum toxin injections to treat four patients suffering from deglutition problems and cricopharyngeal dysphagia of different origins. Botulinum toxin was injected into the cricopharyngeus muscle that was identified by endoscopy under general anesthesia. In this study, no major side effects were observed. Three patients obtained a significant improvement of esophageal symptoms after the first injection. The treatment had limited effect in one patient who had reflux disease and only slight cricopharyngeus dysfunction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11453562     DOI: 10.1007/s00455-001-0059-7

Source DB:  PubMed          Journal:  Dysphagia        ISSN: 0179-051X            Impact factor:   3.438


  23 in total

1.  Endoscopic balloon catheter dilation for treatment of primary cricopharyngeal dysfunction.

Authors:  Sergio Zepeda-Gómez; Aldo Montaño Loza; Francisco Valdovinos; Max Schmulson; Miguel A Valdovinos
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

2.  Intrinsic properties of the adult human mylohyoid muscle: neural organization, fiber-type distribution, and myosin heavy chain expression.

Authors:  Min Ren; Liancai Mu
Journal:  Dysphagia       Date:  2005       Impact factor: 3.438

3.  Gastrointestinal Uses of Botulinum Toxin.

Authors:  Maria Cariati; Maria Michela Chiarello; Marco Cannistra'; Maria Antonietta Lerose; Giuseppe Brisinda
Journal:  Handb Exp Pharmacol       Date:  2021

Review 4.  Botulinum toxin for gastrointestinal disorders: therapy and mechanisms.

Authors:  H Vittal; P F Pasricha
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

5.  Safety of botulinum toxin for dysphagia in oculopharyngeal muscular dystrophy.

Authors:  Sarah Youssof; Ronald M Schrader; Carol Romero-Clark; Gulmohor Roy; Michael Spafford
Journal:  Muscle Nerve       Date:  2014-02-25       Impact factor: 3.217

6.  Treatment of Oropharyngeal Dysphagia.

Authors:  Ian J. Cook
Journal:  Curr Treat Options Gastroenterol       Date:  2003-08

7.  Botulinum toxin injection for the treatment of upper esophageal sphincter dysfunction.

Authors:  Elizabeth A Kelly; Ian J Koszewski; Safwan S Jaradeh; Albert L Merati; Joel H Blumin; Jonathan M Bock
Journal:  Ann Otol Rhinol Laryngol       Date:  2013-02       Impact factor: 1.547

Review 8.  Therapeutic intervention in oropharyngeal dysphagia.

Authors:  Rosemary Martino; Timothy McCulloch
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-09-14       Impact factor: 46.802

9.  Endoscopic CO2 laser-assisted surgery for cricopharyngeal dysfunction.

Authors:  Georges Lawson; Marc Remacle; Jacques Jamart; Jérôme Keghian
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-05-13       Impact factor: 2.503

10.  Dysphagia.

Authors:  Dawn D. F. Ferguson; Kenneth R. DeVault
Journal:  Curr Treat Options Gastroenterol       Date:  2004-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.